CROI 2015 Program and Abstracts

Poster Listings

Session P-M3 Poster Session

Poster Hall

637 A Prognostic Score Estimating the Risk of Liver-Related Death Among HIV/HCV Coinfected Subjects Daniel Grint 1 ; Lars Peters 2 ; Jürgen Rockstroh 3 ; Karine Lacombe 4 ; Andrzej Horban 5 ; Irina Khromova 8 ; Jose Gatell 6 ; Antonella d’Arminio Monforte 7 ; Jens D. Lundgren 2 ; Amanda Mocroft 1 on behalf of EuroSIDA in EuroCoord 1 University College London, London, United Kingdom; 2 University of Copenhagen, Copenhagen, Denmark; 3 University Hospital Bonn, Bonn, Germany; 4 Hospital Saint Antoine, Paris, France; 5 Wojewodzki Szpital Zakazny, Warsaw, Poland; 6 University of Barcelona, Barcelona, Spain; 7 Clinica delle Malattie Infettive e Tropicali, Milan, Italy; 8 Centre for HIV/AIDS & Infectious Diseases Prevention & Control, Kaliningrad, Russian Federation 638 Has Modern ART Reduced Endstage Liver Disease Risk in HIV-Hepatitis Coinfection? Marina B. Klein 1 ; Keri N. Althoff 3 ;Yuezhou Jing 3 ; Greg D. Kirk 3 ;Vincent Lo Re 2 ; Nina Kim 4 ; Mari Kitahata 4 ; ChloeThio 3 ; Michael J. Silverberg 5 ; Richard Moore 3 North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) 1 McGill University Health Centre, Montreal, Canada; 2 University of Pennsylvania, Philadelphia, PA, US; 3 Johns Hopkins University, Baltimore, MD, US; 4 University of Washington, Washington, DC, US; 5 Kaiser Permanente Northern California, Oakland, CA, US 639 Marijuana Use Does Not Accelerate Liver Fibrosis in HCV/HIV-Coinfected Women Erin M. Kelly 1 ; Jennifer L. Dodge 1 ; Monika Sarkar 1 ; Audrey French 2 ; PhyllisTien 1 ; Marshall Glesby 3 ; Elizabeth Golub 4 ; Michael Augenbraun 5 ; Michael Plankey 6 ; Marion G. Peters 1 WIHS 1 University of California San Francisco, San Francisco, CA, US; 2 CORE Center/Stroger Hospital, Chicago, IL, US; 3 Weill Cornell Medical College, New York City, NY, US; 4 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US; 5 State University of New York, Downstate Medical Center, Brooklyn, NY, US; 6 Georgetown University, Washington, DC, US 640 HIV Infection Does Not Worsen Prognosis of Liver Transplantation for Hepatocellular Carcinoma Fernando H. Agüero 1 ; Alejandro Forner 2 ; Christian Manzardo 1 ; AndresValdivieso 3 ; Marino Blanes 4 ; Rafael Barcena 5 ; Antoni Rafecas 1 ; Lluis Castells 6 ; Antonio Rimola 1 ; Jose MMiro 1 1 University of Barcelona, Barcelona, Barcelona, Spain; 2 Hospital Clinic, IDIBAPS and El Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain; 3 Hospital Universitario de Cruces, Bilbao, Spain, Bilbao, Spain; 4 Hospital Universitario La Fe, Valencia, Spain, Valencia, Spain; 5 Hospital Universitario Ramón y Cajal, Madrid, Spain, Madrid, Spain; 6 Hospital Universitari Vall d‘Hebrón, Barcelona, Spain, Barcelona, Spain 641 Rapid Progression to Cirrhosis and Death Among HCV-Infected Persons Who Inject Drugs in India Shruti H. Mehta 1 ; Suniti Solomon 2 ; Allison M. McFall 1 ; Aylur K. Srikrishnan 2 ; Pachamuthu Balakrishnan 2 ; Nandagopal P 2 ; David L.Thomas 1 ; Mark Sulkowski 1 ; Sunil S. Solomon 1 1 Johns Hopkins University, Baltimore, MD, US; 2 YR Gaitonde Centre for AIDS Research and Education, Chennai, India 642 Chronic Kidney Disease Progression After HCV Seroconversion Adeel A. Butt University of Pittsburgh/VA Pittsburgh Healthcare System, Pittsburgh, PA, US Session P-N2 Poster Session Poster Hall 2:30 pm– 4:00 pm HCV Therapy: Observations From Cohort Studies 643 Statins Improve SVR, Reduce Fibrosis Progression and HCC Among HCV+ Persons Adeel A. Butt 1 ; PengYan 2 ; Obaid Shaikh 2 ; Shari Rogal 2 1 University of Pittsburgh/VA Pittsburgh Healthcare System, Pittsburgh, PA, US; 2 VA Pittsburgh Healthcare System, Pittsburgh, PA, US 644 Sofosubuvir, Simeprevir, +/- Ribavirin in HCV Protease Inhibitor- Experienced Patients Kristen M. Marks ; Ethan M.Weinberg; Sonal Kumar; Carrie Down;Ype P. de Jong; Leah A. Burke; Mary C. Olson; Ira M. Jacobson Weill Cornell Medical College, New York, NY, US

2:30 pm– 4:00 pm HIV Detection, Tropism, and CD4 Measurement 630 Accuracy of POC CD4 testing using microtube capillary sampling in Botswana households Sikhulile Moyo 1 ; Lillian Okui 1 ; Hermann Bussmann 1 ; Simani Gaseitsiwe 1 ; Erik van Widenfeldt 1 ; Molly P. Holme 2 ; Joseph Makhema 1 ; Shahin Lockman 2 ;Vladimir Novitsky 2 ; Max Essex 2 1 Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; 2 Harvard School of Public Health, Boston, MA, US 631 Zyomyx MyT4 and BD FACSPresto Comparison to the Pima CD4 Assay Katie Tucker ; Sehin Birhanu; LarryWesterman US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US 632LB Point-of-Care CD4 (Pima) Impact on Linkage to CareWith Home-Based HIV Testing, Kenya Mitesh A. Desai 1 ; Duncan Okal 2 ; RobertT. Chen 1 ; Richard Ndivo 2 ; Charles Lebaron 1 ;Tiffany Williams 1 ; Fred Otieno 2 ; Charles Rose 1 ;Taraz Samandari 1 ; Clement Zeh 1 1 US Centers for Disease Control and Prevention, Atlanta, GA, US; 2 Kenya Medical Research Institute, Kisumu, Kenya 633 Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes Kieran Cashin 1 ; Lachlan R. Gray 1 ; Katherine L. Harvey 1 ; Danielle Perez-Bercoff 2 ; Guinevere Q. Lee 3 ; Jasminka Sterjovski 1 ; James F. Demarest 4 ; Fraser Drummond 4 ; Melissa J. Churchill 1 ; Paul R. Gorry 1 1 Burnet Institute, Melbourne, Australia; 2 Centre Recherche Public de la Santé, Strassen, Luxembourg; 3 BC Centre for Excellence in HIV/AIDS, Vancouver, Canada; 4 ViiV Healthcare, Durham, NC, US 634 Accuracy of Re-Reading HIV Rapid Tests and the Effect of Prolonged High Temperature AugustineT. Choko 1 ; DeusThindwa 1 ; Peter MacPherson 2 ; Rodrick Sambakunsi 1 ; Aaron Mdolo 1 ; Kondwani Chiumya 1 ; Owen Malema 3 ; Simon Makombe 4 ; Emily L.Webb 6 ; Elizabeth L. Corbett 6 1 Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi; 2 University of Liverpool, Liverpool, United Kingdom; 3 Ministry of Health, Blantyre, Malawi; 4 Ministry of Health, Lilongwe, Malawi; 5 London School of Hygiene and Tropical Medicine, London, United Kingdom; 6 London School of Hygiene and Tropical Medicine, London, United Kingdom 635 Analysis of False Negative HIV Tests Based on Oral Fluid in 3 Clinical Trials Marcel E. Curlin 1 ; MichaelT. Martin 1 ;Wanna Leelawiwat 2 ; Roman Gvetadze 1 ; Charles Rose 1 ; Sarika Pattanasin 2 ; Richard Niska 1 ;Timothy Holtz 1 ; Kachit Choopanya 3 ; Janet McNicholl 1 1 US Centers for Disease Control and Prevention, Apo, US; 2 Thailand Ministry of Public Health– Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand; 3 Bangkok Tenofovir Study Group, Bangkok, Thailand 2:30 pm– 4:00 pm Natural History and Prognosis of HCV Infection 636 Progression of Liver Disease in LHIV/HCV Coinfected People According to Gender in Icona Cohort: Role of Age as Potential Different Exposure to Estrogens Antonella Cingolani 1 ; Paola Cicconi 2 ; GloriaTaliani 3 ; Alessandro D. Cozzi-Lepri 4 ; Massimo Puoti 5 ; Carmela Pinnetti 6 ; Pier LuigiViale 7 ; Antonella d’Arminio Monforte 2 for Icona Foundation Study Group 1 Catholic University, Roma, Italy; 2 University of Milano, Milano, Italy; 3 University La Sapienza, Roma, Italy; 4 University College London Medical School, Royal Free Campus, London, United Kingdom, London, United Kingdom; 5 Niguarda Hospital, Milano, Italy; 6 National Institute for Infectious Diseases L. Spallanzani, Roma, Italy; 7 Univeristy of Bologna, Bologna, Italy TUESDAY, FEBRUARY 24, 2015 Session P-N1 Poster Session Poster Hall

Poster Listings

51

CROI 2015